Abstract
Embryonic stem cell tests (EST) are considered promising alternative assays for developmental toxicity testing. Classical mouse derived assays (mEST) are being replaced by human derived assays (hEST), in view of their relevance for human hazard assessment. We have compared mouse and human neural ESTn assays for neurodevelopmental toxicity as to regulation of gene expression during cell differentiation in both assays. Commonalities were observed in a range of neurodevelopmental genes and gene ontology (GO) terms. The mESTn showed a higher specificity in neurodevelopment than the hESTn, which may in part be caused by necessary differences in test protocols. Moreover, gene expression responses to the anticonvulsant and human teratogen valproic acid were compared. Both assays detected pharmacological and neurodevelopmental gene sets regulated by valproic acid. Common significant expression changes were observed in a subset of homologous neurodevelopmental genes. We suggest that these genes and related GO terms may provide good candidates for robust biomarkers of neurodevelopmental toxicity in hESTn. (C) 2015 Elsevier Inc. All rights reserved.
Original language | English |
---|---|
Pages (from-to) | 77-86 |
Number of pages | 10 |
Journal | Reproductive Toxicology |
Volume | 56 |
DOIs | |
Publication status | Published - 15 Aug 2015 |
Funding
This study was supported by grant no 050-060-510 from the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (NWO) provided to the Netherlands Toxicogenomics Centre.
Keywords
- Embryonic stem cells
- Transcriptomics
- Developmental neuro toxicity
- Valproic acid
- Neural differentiation
- VITRO EMBRYOTOXICITY TEST
- IN-VITRO
- DEVELOPMENTAL TOXICITY
- NEURONAL DIFFERENTIATION
- TUBE DEFECTS
- RAT-BRAIN
- CARDIOMYOCYTES
- MESODERM
- TERATOGENICITY
- PROLIFERATION